Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable and Accrued Expenses

3 Months Ended

Mar. 31, 2024

10. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following:


	March 31,		December 31,
($ in thousands)	2024		2023

Accounts payable	$	41,803	$	34,810
Accrued expenses:
Professional fees		1,963		1,681
Salaries, bonus and related benefits		6,586		8,531
Research and development		5,222		11,644
Research and development - milestones		7,000		—
Accrued royalties payable		1,382		2,015
Accrued coupon and rebates		7,169		9,987
Return reserve		2,806		4,077
Other		2,448		817
Total accounts payable and accrued expenses	$	76,379	$	73,562